glaucoma
Conditions
Interventions
Patients with glaucoma suspected of having a diurnal variation in intraocular pressure (IOP) will have a diurnal variation in IOP measured. They will be treated with Ripasudil 0.4% eye drops, and the
Sponsors
Yokohama City University Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Males and females over 20 years of age at the time of registration. 2) Patients with glaucoma with suspected diurnal variation in intraocular pressure (excluding secondary glaucoma) and patients with suspected glaucoma. A difference of 3 mmHg or more between the intraocular pressure at 9:00 a.m. and 2:00 p.m. is considered intraday IOP Patients with suspected fluctuations.
Exclusion criteria
Exclusion criteria: 1) Patients already on Ripasudil 0.4% eye drops 2) Patients who cannot wear contact lenses (patients with contraindicated target diseases as listed in the Triggerfish package insert) 3) Patients who cannot continue to use Ripasudil 0.4% due to hypersensitivity or other problems to eye drops 4) Other patients who are deemed unsuitable for inclusion in the subject by the physician's judgment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary endpoint is the absolute difference between the highest and lowest contactlens sensor values (mVeq), as measured by the trigger fish system before and 2 weeks after the addition of ripasudil 0.4% ophthalmic solution. | — |
Countries
Japan
Contacts
Public ContactMai Ishii
Yokohama City University School of Medicine Department of Ophthalmology
Outcome results
None listed